` CDBT (China Dasheng Biotechnology Co) vs S&P 500 Comparison - Alpha Spread

C
CDBT
vs
S&P 500

Over the past 12 months, CDBT has underperformed S&P 500, delivering a return of -15% compared to the S&P 500's +19% growth.

Stocks Performance
CDBT vs S&P 500

Loading
CDBT
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CDBT vs S&P 500

Loading
CDBT
S&P 500
Difference
www.alphaspread.com

Performance By Year
CDBT vs S&P 500

Loading
CDBT
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
China Dasheng Biotechnology Co vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

China Dasheng Biotechnology Co
Glance View

Market Cap
1.7m USD
Industry
Chemicals

China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.

CDBT Intrinsic Value
Not Available
C
Back to Top